BioVie Inc. (BIVI) vs Lisata Therapeutics, Inc. (LSTA)
A side-by-side comparison of BioVie Inc. and Lisata Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BIVI
BioVie Inc.
$1.45HealthcareDelayed quote: Oct 6, 2026, 3:39 PM EDT
LSTA
Lisata Therapeutics, Inc.
$1.17HealthcareDelayed quote: Oct 6, 2026, 3:29 PM EDT
Total return — BIVI vs LSTA
growth of $100 · dividends reinvested · last 10yBIVI -100.0% (-54.2%/yr)LSTA -98.2% (-32.9%/yr)LSTA compounded faster over this window
Log scale — wide-divergence pair
BIVI LSTA
BIVI vs LSTA: by the numbers
- •BIVI is the larger company ($11M vs $11M market cap).
- •Both run net losses; BIVI's is the smaller (0.00% vs -14621.00% net margin).
Metrics side by side
Valuation
| Metric | BIVI | LSTA |
|---|---|---|
| P/S ratio | N/A | 106.54 |
| P/B ratio | 1.06 | 1.29 |
Profitability
| Metric | BIVI | LSTA |
|---|---|---|
| Gross margin | 0.00% | 14.12% |
| Operating margin | 0.00% | -10711.18% |
| Net margin | 0.00% | -14621.00% |
| ROE | -214.92% | -177.35% |
| ROIC | -216.67% | -204.32% |
Growth (annualized)
| Metric | BIVI | LSTA |
|---|---|---|
| Total return CAGR (5Y) | -70.37% | -40.75% |
Frequently asked
- How have BIVI and LSTA total returns compared?
- Over the past 10 years, BIVI delivered -54.09% and LSTA delivered -32.84% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.